Author:
Jacobs E,Watson S A,Michaeli D,Ellis I O,Robertson J F R
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Beatson, G. T. (1896). On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii: 104–107.
2. Blamey, R. W., Jonat, W., Kaufmann, M., Raffaele Bianco, A. & Namer, M. (1992). Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer 28A: 810–814.
3. Cho, H., Aronica, S. M. & Katzenellenbogen, B. S. (1994). Regulation of progesterone receptor gene expression in MCF7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, oestradiol, insulin-like growth factor-1 and serum factors. Endocrinology 134: 658–664.
4. Dowsett, M., Goss, P. E., Powles, T. J., Hutchinson, G., Brodie, A. M. H., Jeffcoate, S. L. & Coombes, R. C. (1987). Use of the aromatase inhibitor 4 hydroxyandrostenedione in postmenopausal breast care: optimisation of therapeutic dose and route. Cancer Res 47: 1957–1961.
5. Ferro, V. A. & Stimpson, W. H. (1997). Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer 33: 1468–1478.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献